DNA/RNA
Description 51-52 exons spanning about 63 kb.
Transcription
In a telomeric to centromeric direction. 10kb mRNA.
Protein
Description 2349 amino acids, 267 kDa. The protein contains extensive coiled-coil domains and an acidic globular Cterminus, and is phosphorylated.
Expression
Widespread, if not ubiquitous; highest in testis, thymus, spleen and brain, lower levels in heart, liver and kidney.
Localisation
Nucleoplasmic side of the nucleopore and discrete foci in the nuclear interior, binds to the nucleoporin Nup98.
Function
Still controversial, part of a filamentous intranuclear network, role in nuclear protein and/or polyA+RNA export.
Homology
Yeast Mlp1 and Mlp2, drosophila Bx34, xenopus Tpr.
Mutations
Note Tpr was first described as a fusion partner with the MET oncogene (7q) in a cell line rendered tumorigenic with the direct acting carcinogen N-methyl-N-primenitrosoguanidine (MNNG). Then, this Tpr-MET rearrangement was also described in gastric cancers and a TRK-Tpr fusion was found in thyroid cancers. Fusions with at least one other proto-oncogene have since been described.
Implicated in

Gastric cancers with TPR-MET hybrid gene
Disease
The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. 
Rat induced tumors (adenocarcinomas and fibroblastomas) with Tpr-raf
Breakpoints
Note
All TRK breakpoints fall within a 2,9 kb genomic region of NTRK1. In the Tpr locus, the TRK-T1 and TRK-T2 break points are at least 11 kb apart, indicating the absence of a region prone to rearrangements.
